How all cancer patients were cured after taking an experimental drug - Smashing Health Guide

Revolutionary study in the US: All cancer patients have been cured after taking an experimental drug
Revolutionary study in the US All cancer patients have been cured after taking an experimental drug


A dozen rectal cancer patients in the United States have noticed that the tumor has disappeared after undergoing experimental immunotherapy, informs Euro news.

The patients, who were part of a small clinical study conducted by researchers at the Sloan Kettering Memorial Cancer Center (MSK) in New York, USA, saw how the tumors disappeared after being treated with an experimental drug called Dostarlimab.

Details of this study were published Sunday in the New England Journal of Medicine. The study described the results of 12 patients with rectal cancer, all of whom were cured after treatment with Dostarlimab.

Participants received a dose of Dostarlimab every three weeks for six months, the idea being that, after treatment, they should have followed standard chemotherapy, radiotherapy and surgery.


However, the researchers found that in each case, the cancer was eliminated only after experimental treatment.


"I think this is the first time this has happened in the history of cancer," said Dr. Luis Diaz Jr. of Memorial Sloan Kettering (MSK), one of the study's authors.

"It's incredibly satisfying to see tears of happiness and to receive e-mails from patients in this study who are finishing treatment and say, 'Oh, my God, I can keep all my normal body functions that I feared -I could have lost due to radiation or surgery ", said Dr. Andrea Cercek from MSK, coordinator of the study.


How does this immunotherapy work?

In this study, the researchers wanted to see what Dostarlimab can do if it was used before cancer cells began to spread in the body.

This type of treatment focuses on certain proteins called checkpoints, which are produced by some types of immune system cells as well as some cancer cells, according to the US National Cancer Institute.

Checkpoints, which prevent the immune response from being too strong, can sometimes prevent the immune cells from actually killing the cancer cells. Dostarlimab is a "checkpoint inhibitor" that essentially "releases" immune cells that can recognize and attack cancer cells, according to MSK.

Read the full story: Revolutionary study in the US: All cancer patients have been cured after taking an experimental drug

The research found that at least 14 patients had cancerous tumors and none had significant side effects.

Post a Comment

0 Comments